Michael L. Dumas

Characterization of human angiotensinogen.

Duane A. Tewksbury, Wayne L. Frome, Michael L. Dumas · Journal of Biological Chemistry · 1978 · 42 citations · Full text

Hypertension, Electrolyte Disorder, Glycobiology +22

Inactivation of Hepatitis C Virus in Low pH Intravenous Immunoglobulin

Robert Louie, Cynthia J. Galloway, Michael L. Dumas et al. · Biologicals · 1994 · 41 citations

Viral Persistence, Hepatitis C, Hepatitis C Virus +7

Engineering Novel VPAC2-Selective Agonists with Improved Stability and Glucose-Lowering Activity in Vivo

Clark Q. Pan, Fugang Li, Irene Tom et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 27 citations

A preparation of modified immune serum globulin (human) suitable for intravenous administration

Duane D. Schroeder, Michael L. Dumas · The American Journal of Medicine · 1984 · 15 citations

Translational Medicine, Immunocytochemical Technique, Autoimmune Disease +13

Reproductible production of a PEGylated dual-acting peptide for diabetes

Irene Tom, Vivian Lee, Michael L. Dumas et al. · The AAPS Journal · 2007 · 12 citations · Full text

Biochemistry, Peptide Engineering, Diabetes +2